Methods for altering acetic acid production and enhancing cell death in bacteria
Abstract
Methods of increasing cultured cell growth yields and/or protein production from bacterial cell cultures are provided. More particularly, mutant bacterial cells having an alteration in the expression or activity of the cidABC operon, a gene therein, or a homolog or a regulator thereof, and methods for reducing acetic acid/acetate production in cultures are provided, as are methods for increasing cultured cell growth yields and/or protein production employing such cells. Methods for enhancing bacterial cell death and methods for identifying agents that increase the susceptibility of bacteria to cell death are also provided.
Claims
exact text as granted — not AI-modified1 . An isolated bacterial cell, comprising a mutation in a cidABC operon homolog, wherein the mutation measurably reduces acetate production by the cell when the cell is cultured in medium comprising a metabolizable carbon source, in comparison to an isogenic cell not comprising the mutation and cultured under identical conditions to the isolated cell.
2 . The isolated cell of claim 1 , wherein the mutation is an inactivating mutation in a cidC homolog encoding a pyruvate oxidase.
3 . The isolated cell of claim 1 , wherein the isolated cell is of a gram positive species.
4 . The isolated cell of claim 1 , wherein the isolated cell is of a gram negative species.
5 . The isolated cell of claim 4 , wherein the gram negative species is E. coli.
6 . The isolated cell of claim 2 , wherein the homolog of cidC is poxB.
7 . The isolated cell of claim 1 , wherein the mutation is a knockout mutation.
8 . A method of increasing yield in a bacterial cell culture, comprising:
culturing the isolated bacterial cell of claim 1 ,
wherein the reduced acetate production results in increased yield, and wherein increased yield is measured as an increase in bacterial biomass, an increase in production of a product, an increase in turbidity, an increase in optical density, or a combination of two or more thereof.
9 . The method of claim 8 , wherein the mutation is an inactivating mutation in a cidC homolog encoding a pyruvate oxidase.
10 . The method of claim 8 , wherein the isolated cell is of a gram positive species.
11 . The method of claim 8 , wherein the isolated cell is of a gram negative species.
12 . The method of claim 11 , wherein the gram negative species is E. coli.
13 . The method of claim 9 , wherein the homolog of cidC is poxB.
14 . The method of claim 8 , wherein the mutation is a knockout mutation.
15 . A method of producing a polypeptide, comprising:
culturing the isolated cell of claim 1 in culture medium to produce a bacterial cell culture, wherein the isolated cell comprises a nucleic acid encoding the polypeptide; and isolating the polypeptide from the bacterial cell culture.
16 . The method of claim 15 , wherein the mutation is an inactivating mutation in a cidC homolog encoding a pyruvate oxidase.
17 . The method of claim 15 , wherein the isolated cell is of a gram positive species.
18 . The method of claim 15 , wherein the isolated cell is of a gram negative species.
19 . The method of claim 18 , wherein the gram negative species is E. coli.
20 . The method of claim 16 , wherein the cidC homolog is poxB.Join the waitlist — get patent alerts
Track US2011020869A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.